February 8, 2012
| Bio-IT World > Easing In to Ease of Use


Easing In to Ease of Use



April 14, 2006 | Bioinformatics and related information technologies are undergoing a paradigm shift where the prototypical use-case is changing from a very small set of highly specialized individuals operating on fantastically expensive, custom supercomputing systems to encompassing all scientific researchers on large operating systems that can be purchased affordably off the rack. This dramatic change in user profile requires an appropriate response from the producers of these technologies to provide a level of “ease of use” that is consistent with the large-volume, low-cost, and less specialized user.

If you read your computing history (or are old enough to remember), we witnessed a similar paradigm shift in research computing once before. During the early days of the first computer-aided scientific research, scientists did all of their own programming, data entry, computer operation, and computer repairs. Because these computers were so costly, it was considered of utmost importance to keep them in continual use. This led to the development of the first operating systems, which were essentially batch processing programs, where instead of operating the computers themselves, scientists would put their programs onto punch cards and turn them over to a computer operator. The computer operator, a semi-skilled laborer, would load up each program, run it, and collect the results for the scientist. Because the cost of the computer and the programmer were so large relative to the data-entry personnel, programs were written for the convenience of the computer and the programmer, rather than for the computer operator. This approach of having the user conform to the computer and programmer lasted long after the price of computers and programmers had dropped, and what had at one time made a lot of economic sense continued long after the economic model had reversed. We all know what happened there, right? Computers became sufficiently inexpensive that anyone could own one (or more), and the computer human interface became simple enough that children could operate them.

History Repeats
Bio-IT is repeating this computing history. In recent years past, due to the high cost and novelty of supercomputing for bioinformatics research, it has been common to witness a Ph.D.-level scientist up to his or her elbows in supercomputing hardware infrastructure design, mucking with RAM, disks, CPUs, and networking. As computing hardware costs have dropped such that supercomputing resources are well within reach of small academic research laboratories, a researcher is still required to conform to the computer. The ease of use is not there yet. A large number of shared network services must be installed and configured by IT professionals to transform the many discrete computers into a single virtualized compute resource, and the scientists are still plunking away at the UNIX command-line, writing their own data analysis algorithms and high-performance parallelization batch processing routines. This reminds me of roughly the point in time just after I bought my first personal computer (Timex Sinclair 1000, with BASIC command-line shell), and just before I bought my fourth (Atari 520 ST, with a point-and-click graphical user interface). That is to say, scientists can afford to buy the computer but still have to work quite hard and with a clumsy interface to get their work done.

What must and will occur in bio-IT is the equivalent advances in ease of use as the transition from the BASIC command-line shell to the point-and-click graphical user interface. I’m not at all sure when this will occur or what the solution will ultimately look like, but I know the ease of use I’m looking for. Massive and massively scalable compute resources will be self-assembling. I’m not talking nanobots that will do the racking and stacking, but rather they will require zero configuration of any shared network services, involving no more than placing two or more computers on the same network. As a user, whether I’m performing some data analysis as a single-threaded processes on my laptop, or as a highly parallel, high-performance analysis executing over many discrete remote systems, I as a user won’t know or even care. I will simply get the results I’m looking for right now. All of my data analysis algorithms will be knowledgeable of data types they accept and data types they produce and will thereby inter-operate, and each of these algorithms will be accessible directly from my desktop and from within my desktop productivity tools. The ease of use I’m looking for is for bioinformatics research tools to be as simple to use as my iPod.

E-mail Bill Van Etten at bill@bioteam.net.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 





For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .